Medicine & Life Sciences
Cannabinoid Receptor CB2
100%
Cannabinoids
99%
Cannabinoid Receptors
92%
Cannabinoid Receptor CB1
91%
Cannabidiol
69%
Endocannabinoids
54%
Dronabinol
45%
Cannabis
38%
Ligands
36%
Pharmacology
33%
Cannabinoid Receptor Agonists
26%
tetrahydrocannabivarin 9
25%
3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol
22%
Rimonabant
19%
Cannabinoid Receptor Antagonists
17%
4-quinolone-3-carboxylic acid
16%
anandamide
16%
glyceryl 2-arachidonate
14%
Receptor, Serotonin, 5-HT1A
13%
5-chloro-3-ethyl-1H-indole-2-carboxylic acid (2-(4-piperidin-1-yl-phenyl)ethyl)amide
13%
In Vitro Techniques
13%
HU 211
13%
resorcinol
12%
fatty-acid amide hydrolase
12%
Guanosine 5'-O-(3-Thiotriphosphate)
12%
Cricetulus
11%
Allosteric Site
11%
3-(2-nitro-1-phenylethyl)-2-phenyl-1H-indole
10%
TRPV1 receptor
10%
olivetol
10%
Amides
10%
cannabidiolic acid
9%
cannabigerol
9%
Pyrazoles
8%
Brain
8%
Nausea
8%
TRPV Cation Channels
8%
Spatial Memory
8%
Vomiting
8%
nabiximols
7%
Quinolones
7%
iodopravadoline
7%
4-Quinolones
7%
8-Hydroxy-2-(di-n-propylamino)tetralin
7%
Multiple Sclerosis
7%
CHO Cells
7%
GAT100
7%
Fatty Acids
7%
AM 251
7%
Ankyrins
6%
Chemical Compounds
Cannabinoid
66%
Cannabinoid 2 Receptor Agonist
19%
Endocannabinoid
16%
Cannabinoid Receptor Agonist
14%
Inverse Agonist
13%
Ligand
13%
Phytocannabinoid
11%
Agonist
9%
Cannabinoid Receptor Antagonist
6%
Cannabinoid 1 Receptor Antagonist
5%
Pyrazoles
5%
2-Arachidonoylglycerol
5%
Antagonist
5%
Anandamide
5%
1,2,3-triazolyl Group
5%